US Stock MarketDetailed Quotes

VSee Health (VSEE)

Watchlist
  • 0.0162
  • +0.0002+1.19%
15min DelayClose Sep 18 15:17 ET
917.65KMarket Cap-0.04P/E (TTM)

VSee Health (VSEE) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
Total Revenue as Reported
+48.02%1.56M
-4.86%3.16M
+5.13%3.93M
+18.67%3.98M
-38.35%1.06M
+104.90%3.32M
+161.52%3.73M
+131.11%3.35M
+32.66%1.71M
--1.62M
--1.43M
--1.45M
--1.29M
Total Operating Revenue
+48.02%1.56M
-4.86%3.16M
+5.13%3.93M
+18.67%3.98M
-38.35%1.06M
+104.90%3.32M
+161.52%3.73M
+131.11%3.35M
+32.66%1.71M
--1.62M
--1.43M
--1.45M
--1.29M
Cost of Revenue
+208.02%1.36M
+34.25%1.96M
+54.57%2.09M
+234.78%1.91M
-52.90%440.15K
+278.38%1.46M
+233.97%1.35M
+19.09%569.73K
+97.05%934.57K
--386.25K
--405.19K
--478.40K
--474.29K
Gross Profit
-66.48%206.15K
-35.58%1.20M
-22.97%1.83M
-25.55%2.07M
-20.84%615.04K
+50.64%1.86M
+132.82%2.38M
+186.18%2.78M
-4.77%777.00K
--1.23M
--1.02M
--973.07K
--815.94K
Operating Expense
+33.73%2.90M
+13.03%4.17M
-0.99%5.27M
+4.61%4.13M
+46.58%2.17M
+234.25%3.69M
+293.57%5.33M
+218.86%3.95M
+4.98%1.48M
--1.10M
--1.35M
--1.24M
--1.41M
Selling and Admin Expenses
+33.73%2.90M
+13.03%4.17M
-0.99%5.27M
+4.61%4.13M
+46.58%2.17M
+234.25%3.69M
+293.57%5.33M
+218.86%3.95M
+4.98%1.48M
--1.10M
--1.35M
--1.24M
--1.41M
-General & Admin Expense
+33.73%2.90M
+13.03%4.17M
-0.99%5.27M
+4.61%4.13M
+46.58%2.17M
+234.25%3.69M
+293.57%5.33M
+218.86%3.95M
+4.98%1.48M
--1.10M
--1.35M
--1.24M
--1.41M
Operating Profit
-73.34%-2.70M
-62.41%-2.97M
-16.78%-3.44M
-76.77%-2.06M
-120.96%-1.56M
-1504.41%-1.83M
-790.90%-2.95M
-338.75%-1.16M
-18.34%-704.22K
--130.40K
---330.57K
---265.29K
---595.07K
Net Non-Operating Interest Income (Expense)
+63.71%-80.70K
+84.52%-113.10K
-525.27%-1.08M
-555.08%-755.87K
+34.95%-222.36K
-7748.17%-730.67K
+1019.21%255.07K
-217.76%-115.39K
-328.04%-341.84K
---9.31K
---27.75K
---36.31K
---79.86K
Non-Operating Interest Expense
-63.71%80.70K
-84.52%113.10K
+525.27%1.08M
+555.08%755.87K
-34.95%222.36K
+7748.17%730.67K
-1019.21%-255.07K
+217.76%115.39K
+328.04%341.84K
--9.31K
--27.75K
--36.31K
--79.86K
Total Other Finance Costs
----
----
----
----
----
--138.02K
--895.00K
----
--1.62M
----
----
----
----
Other Income (Expense)
-158.79%-320.32K
+136.91%510.85K
-566.61%-3.28M
+104.79%2.52M
+90.47%-123.78K
-5154.58%-1.38M
-1180.21%-491.42K
-171375.55%-52.63M
-1904.59%-1.30M
---26.34K
--45.49K
---30.70K
--71.95K
Gain on Sale of Security
-13.12%-175.14K
+111.34%143.04K
-2511.67%-2.86M
-50.70%2.83M
-128.25%-154.83K
---1.26M
-4775.85%-109.61K
+26627.38%5.74M
+522.78%548.10K
----
---2.25K
---21.63K
--88.01K
Special Income (Charges)
--0.00
--367.81K
-15.50%-95.08K
+100.00%0.00
+100.00%0.00
+100.00%0.00
-194.10%-82.32K
-637193.44%-57.78M
-1321.68%-228.31K
---26.34K
--87.47K
---9.07K
---16.06K
-Less:Restructuring and Mergern & Acquisition
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
+303.75%82.32K
+4927.95%455.83K
+1321.68%228.31K
--26.34K
--20.39K
--9.07K
--16.06K
-Less:Impairment of Capital Assets
----
----
--0.00
-100.00%0.00
----
----
--0.00
--56.68M
----
----
--0.00
--0.00
----
-Less:Other Special Charges
----
---367.81K
--95.08K
----
--126.13K
----
--0.00
--645.98K
----
----
----
----
----
Other Non-Operating Income (Expenses)
-567.55%-145.17K
----
-6.24%-318.18K
+48.74%-305.01K
+101.92%31.05K
---122.48K
-653.77%-299.50K
---595.00K
-53941166.67%-1.62M
----
---39.73K
----
--3.00
Pretax Profit
-62.88%-3.10M
+34.70%-2.58M
-145.17%-7.80M
+99.46%-289.75K
+18.86%-1.90M
-4264.58%-3.95M
-916.98%-3.18M
-16124.57%-53.91M
-288.82%-2.34M
--94.75K
---312.83K
---332.30K
---602.98K
Tax
-1135.82%-17.90K
+75.77%23.74K
+89.01%50.44K
-100.00%0.00
+100.10%1.73K
--13.51K
-98.90%26.69K
+103.77%8.80K
-862.41%-1.68M
--0.00
--2.43M
---233.72K
---174.40K
Net Profit
+132.42%847.27K
+34.33%-2.60M
-144.70%-7.85M
+99.46%-289.75K
-292.32%-2.61M
-4278.83%-3.96M
-16.99%-3.21M
-54598.74%-53.92M
-55.42%-666.10K
--94.75K
---2.74M
---98.58K
---428.58K
Profit from Continuing Operations
-61.79%-3.08M
+34.33%-2.60M
-144.70%-7.85M
+99.46%-289.75K
-185.83%-1.90M
-4278.83%-3.96M
-16.99%-3.21M
-54598.74%-53.92M
-55.42%-666.10K
--94.75K
---2.74M
---98.58K
---428.58K
Net Income from Discontinuous Operations
+653.71%3.93M
----
----
----
---709.35K
----
----
----
----
----
----
----
----
Minority Interests
----
----
----
----
+100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-705.34%-31.98K
--31.98K
--33.75K
--12.47K
---3.97K
Net Income to Parent Company
+132.42%847.27K
+34.33%-2.60M
-144.70%-7.85M
+99.46%-289.75K
-312.11%-2.61M
-6407.85%-3.96M
-15.56%-3.21M
-48458.76%-53.92M
-49.34%-634.12K
--62.77K
---2.78M
---111.05K
---424.61K
Net Income to Common Stockholders
+132.42%847.27K
+34.33%-2.60M
-144.70%-7.85M
+99.46%-289.75K
-312.11%-2.61M
-6407.85%-3.96M
-15.56%-3.21M
-48458.76%-53.92M
-49.34%-634.12K
--62.77K
---2.78M
---111.05K
---424.61K
Basic EPS
+106.25%0.01
+79.17%-0.05
-20.15%-0.24
+99.44%-0.02
-33.33%-0.16
-2500.00%-0.24
+67.10%-0.20
-14857.80%-3.58
-31.12%-0.12
--0.01
---0.60
---0.02
---0.09
Diluted EPS
+106.25%0.01
+79.17%-0.05
-20.15%-0.24
+99.44%-0.02
-33.33%-0.16
-2500.00%-0.24
+67.10%-0.20
-14857.80%-3.58
-31.12%-0.12
--0.01
---0.60
---0.02
---0.09
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q2
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More